Aurelie Kamoun

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Deep learning assessment of metastatic relapse risk from digitized breast cancer histological slides.

Deep learning assessment of metastatic relapse risk from digitized breast cancer histological slides.

Journal: Nature communications
Published: October 10, 2024

Validation of MSIntuit as an AI-based pre-screening tool for MSI detection from colorectal cancer histology slides.

Validation of MSIntuit as an AI-based pre-screening tool for MSI detection from colorectal cancer histology slides.

Journal: Nature communications
Published: March 28, 2023

Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma.

Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma.

Journal: Nature communications
Published: October 25, 2022

Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies.

Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies.

Journal: Frontiers in oncology
Published: April 28, 2022

FGFR3 Mutational Activation Can Induce Luminal-like Papillary Bladder Tumor Formation and Favors a Male Sex Bias.

FGFR3 Mutational Activation Can Induce Luminal-like Papillary Bladder Tumor Formation and Favors a Male Sex Bias.

Journal: European urology
Published: November 03, 2021

CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.

CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.

Journal: Neuro-oncology
Published: December 14, 2019

Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5.

Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5.

Journal: European urology
Published: December 08, 2019

A deep learning model to predict RNA-Seq expression of tumours from whole slide images.

A deep learning model to predict RNA-Seq expression of tumours from whole slide images.

Journal: Nature communications
Published: October 28, 2019

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer.

Journal: European urology
Published: May 03, 2019

Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy.

Cystathionine as a marker for 1p/19q codeleted gliomas by in vivo magnetic resonance spectroscopy.

Journal: Neuro-oncology
Published: February 07, 2019

Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive disease.

Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive disease.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 27, 2018

Mutational Profile of Aggressive, Localised Prostate Cancer from African Caribbean Men Versus European Ancestry Men.

Mutational Profile of Aggressive, Localised Prostate Cancer from African Caribbean Men Versus European Ancestry Men.

Journal: European urology
Published: June 08, 2018
Showing 1-12 of 23

Last Updated: 09/26/2026